UKRI Translation: MRC Proof of Concept: stage one

Résumé

This Medical Research Council (MRC) call offers funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions at the proof-of-concept stage. Applicants must be employed at a research organisation eligible for MRC funding. The application deadline is 18 November 2026.

This call is focused on medical research and development of therapeutics, medical devices, and diagnostics—sectors outside Acme Corporation's core domain of semiconductors and AI. The eligibility requirement for researchers employed at MRC-eligible research organisations further excludes Acme as an industrial company. The call has no alignment with the client's strategic priorities.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

This funding opportunity was previously titled ‘Developmental pathway funding scheme: stage one’. Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be employed at a research organisation eligible for Medical Research Council (MRC) funding.